Smart move. Any failure of tt034 we can then seperate that from benitec!
But that was ages ago.
Tt034 is obviously a success. Its working guys. We are curing hep c with one injection and validating our tech which will cure aids, lung cancer, hep b, new pain management, and many others. At 70m MC bargain of the century.
Why would they be IPOing in the USA?
Theres been all amazing data so far from 5 parients NO SAFETY ISSUES.
The calm before the storm. Eerily quiet.
Tick tick tick BOOM.
$4 by october when efficacy announced and IPO strts.
